# Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects

> **NCT06529445** · PHASE1 · COMPLETED · sponsor: **Jiangsu vcare pharmaceutical technology co., LTD** · enrollment: 84 (actual)

## Conditions studied

- Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion

## Interventions

- **DRUG:** High Dose VC004 Capsules
- **DRUG:** Median Dose VC004 Capsules
- **DRUG:** Low Dose VC004 Capsules

## Key facts

- **NCT ID:** NCT06529445
- **Lead sponsor:** Jiangsu vcare pharmaceutical technology co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-22
- **Primary completion:** 2024-08-26
- **Final completion:** 2024-08-26
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2024-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06529445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06529445, "Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06529445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*